busulfan has been researched along with Cholera Infantum in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Busulfan has been previously only available in an oral formulation due to its poor water solubility." | 2.69 | A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation. ( Apperley, J; Craddock, C; Eades, A; Goldman, J; Hassan, M; Kanfer, E; Matthews, J; Nilsson, C; Olavarria, E; Timms, A, 2000) |
| " We investigated a 6-h and a 34-h infusion of VP-16 to compare pharmacokinetic parameters and toxicity." | 2.67 | Pharmacokinetics of high-dose VP-16: 6-hour infusion versus 34-hour infusion. ( Bewermeier, P; Hossfeld, DK; Krüger, W; Mross, K; Reifke, J; Stockschläder, M; Zander, A, 1994) |
| "To evaluate the toxic extramedullary morbidity of the conditioning treatment with BuCy for BMT, as well as the usefulness of pentoxyphyllin (PTX) and methylprednisolone (MP) in the prophylaxis of mucositis." | 2.39 | [Extramedullary toxicity in bone marrow transplantation using busulfan and cyclophosphamide conditioning]. ( Maldonado, J; Pascual, MJ, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouazzaoui, A | 1 |
| Dickhöfer, S | 1 |
| Kreuz, M | 1 |
| Huber, E | 1 |
| Holler, E | 1 |
| Wolff, D | 1 |
| Pascual, MJ | 1 |
| Maldonado, J | 1 |
| Mross, K | 1 |
| Bewermeier, P | 1 |
| Reifke, J | 1 |
| Krüger, W | 2 |
| Stockschläder, M | 2 |
| Zander, A | 2 |
| Hossfeld, DK | 1 |
| Srivastava, A | 1 |
| Bradstock, KF | 1 |
| Szer, J | 1 |
| de Bortoli, L | 1 |
| Gottlieb, DJ | 1 |
| Kalhs, P | 1 |
| Peters, S | 1 |
| Zeller, W | 1 |
| Kabisch, H | 1 |
| Lechner, K | 1 |
| Beelen, DW | 2 |
| Sayer, HG | 1 |
| Franke, M | 1 |
| Scheulen, ME | 1 |
| Quabeck, K | 2 |
| Mohnke, M | 1 |
| Oidtmann, M | 1 |
| Schaefer, UW | 2 |
| Olavarria, E | 1 |
| Hassan, M | 1 |
| Eades, A | 1 |
| Nilsson, C | 1 |
| Timms, A | 1 |
| Matthews, J | 1 |
| Craddock, C | 1 |
| Kanfer, E | 1 |
| Apperley, J | 1 |
| Goldman, J | 1 |
| Perez-Ceballos, E | 1 |
| Vallejo, C | 1 |
| Cano, H | 1 |
| Ayala, F | 1 |
| Martínez, F | 1 |
| Moraleda, J | 1 |
| Vicente, V | 1 |
| Schilcher, RB | 1 |
| Ehrlich, R | 1 |
| Schmidt, U | 1 |
| Szy, D | 1 |
| Grosse-Wilde, H | 1 |
| Becher, R | 1 |
1 review available for busulfan and Cholera Infantum
| Article | Year |
|---|---|
[Extramedullary toxicity in bone marrow transplantation using busulfan and cyclophosphamide conditioning].
Topics: Adolescent; Adult; Anemia, Refractory, with Excess of Blasts; Arrhythmias, Cardiac; Bone Marrow Tran | 1995 |
3 trials available for busulfan and Cholera Infantum
| Article | Year |
|---|---|
Pharmacokinetics of high-dose VP-16: 6-hour infusion versus 34-hour infusion.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan | 1994 |
Constant intravenous pentoxifylline infusions in allogeneic marrow transplant recipients: results of a dose escalation study.
Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Dose-Response R | 1993 |
A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation.
Topics: Acute Disease; Adult; Busulfan; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Cyc | 2000 |
5 other studies available for busulfan and Cholera Infantum
| Article | Year |
|---|---|
Cytostatic conditioning in experimental allogeneic bone marrow transplantation: Busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitution.
Topics: Animals; B-Lymphocytes; Bone Marrow Transplantation; Busulfan; Cytostatic Agents; Female; Gastrointe | 2014 |
Busulphan and melphalan prior to autologous bone marrow transplantation.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone | 1993 |
Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients.
Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Child; Cyclophosphami | 1993 |
Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cytomegalovirus Infections; Fatal Outcome; | 2001 |
High-dose 1,2,4-triglycidylurazol given in regimens preparatory to bone marrow transplantation. A preclinical pharmacology study.
Topics: Animals; Antineoplastic Agents; Bone Marrow Transplantation; Busulfan; Dogs; Drug Evaluation, Precli | 1991 |